Financial Health Assessment: GREENGENGROUP.CO.UK LIMITED

1. Financial Health Score: F

Grade Justification: The company is in critical financial condition — technically insolvent with net liabilities approaching £1 million, dormant with no trading activity, and carrying deeply negative retained earnings exceeding £4.5 million. This is the financial equivalent of a patient in a persistent vegetative state: technically alive but showing no vital signs of economic activity, sustained only by external support (creditors not demanding repayment).

2. Key Vital Signs

Trend Analysis (Net Assets over 10 years):

*The 2017-2019 positive figures appear inconsistent with the surrounding years and may reflect different accounting treatments or restatements.

**The 2023 figure of (£890) appears anomalous and may reflect a filing error or different accounting basis.

3. Diagnosis

Primary Condition: Chronic Insolvency with Dormancy

The financial data reveals a company suffering from multiple severe conditions:

a) Technical Insolvency (Critical)

The company's liabilities exceed its assets by approximately £982,000. In medical terms, this is like a patient whose debts to their organs exceed their capacity to function — the body corporate cannot survive without external life support.

b) Revenue Anorexia (Critical)

The company has been dormant since at least 2020, with the directors' report explicitly stating: "The Company is presently dormant and not trading." No revenue means no circulatory system for the business — cash is not flowing through the organisation.

c) Creditor Dependency (Severe)

With current liabilities of £982,994 against current assets of just £1,141, the company has a current ratio of approximately 0.001:1. This is the financial equivalent of being kept alive on life support — the company only continues because creditors (likely related parties or the parent company, R Energy Group Limited) have not demanded repayment.

d) Capital Erosion (Severe)

Share capital of £3,611,000 has been entirely consumed, with retained losses of £4,592,853 creating a shareholders' deficit. This represents a complete erosion of the original investment — like a patient who has exhausted all reserves.

e) Stagnation (Chronic)

The financial position has remained virtually unchanged for five years (2020-2025), with net liabilities hovering around £975,000-£982,000. This chronic stagnation suggests the company is being maintained in a dormant state rather than being either revived or properly wound up.

Underlying Causes:

• Previous Name Changes: The company was originally "HS 488 LIMITED" (2009), then "FARMGEN LIMITED" (until 2017), suggesting previous business pivots that ultimately failed
• Biotechnology Focus: The SIC code (72110 - Research and experimental development on biotechnology) combined with "generation of electricity" suggests the company was involved in green energy/biotech, a capital-intensive sector
• Parent Company Support: R Energy Group Limited (owning >75%) appears to be keeping the company alive, possibly for strategic or tax reasons

4. Recommendations

Immediate Actions (Critical — Within 30 Days)

1. Viability Assessment: Conduct an honest assessment of whether this company has any realistic path to trading profitability. If not, begin formal dissolution proceedings.

2. Creditor Negotiations: If the company is to continue, formally renegotiate or restructure the £982,994 in liabilities. Given the parent company relationship, this may involve converting debt to equity within the group.

3. Board Review: The recent resignation of Linda Rigby (March 2026) reduces board capacity. Evaluate whether the remaining directors can fulfil their duties adequately.

Short-Term Actions (Within 90 Days)

4. Strategic Decision: Choose one of three paths: - Resuscitation: Develop a funded business plan with realistic revenue projections and secure investment before recommencing trading - Hibernation: If maintaining the company for regulatory/strategic reasons, formally document why and ensure compliance with dormant company rules - Termination: If no viable purpose exists, initiate members' voluntary liquidation or strike-off

5. Related Party Review: Clarify the nature of the £982,994 in liabilities — are these owed to the parent company R Energy Group Limited? If so, consider formal debt forgiveness or conversion to equity to clean up the balance sheet.

Medium-Term Actions (Within 12 Months)

6. Group Restructuring: Work with R Energy Group Limited to determine this company's role within the corporate group. Is it a vehicle for future projects, or a legacy entity that should be wound up?

7. Tax Position Review: Consult with tax advisors about any implications of maintaining a dormant company with accumulated losses, including any potential loss relief that could be utilised within the group.

8. Filing Compliance: Continue to ensure timely filings — the company is currently compliant, which is one positive note in an otherwise concerning picture.

Prognosis

Poor to Guarded — Without significant intervention, this company will remain in a persistent dormant and insolvent state. The condition is stable but not self-sustaining. Like a patient on long-term life support, the company continues to exist only through external support (creditor forbearance, likely from the parent company).

The slight deterioration from (£981,803) to (£981,853) in net liabilities suggests minimal ongoing costs are accruing (perhaps administrative or filing costs), slowly deepening the deficit each year.

Recovery potential depends entirely on: - Whether R Energy Group Limited has strategic plans for this entity - Whether the accumulated tax losses have value within the group - Whether the biotechnology/green energy focus has future commercial potential

Without a clear strategic purpose and funded business plan, the most responsible course of action would be an orderly wind-up.